Evidence map›Paper›PMID 23892244›Full record

ArticleGut microbes

Enterotoxigenic Escherichia coli: Orchestrated host engagement.

James M Fleckenstein, George M Munson, David A Rasko

Abstract readComment
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. EnterotoxigenicFrontiers in immunology · 2022
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. HldE Is Important for Virulence Phenotypes in EnterotoxigenicFrontiers in cellular and infection microbiology · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

James M FleckensteinDepartment of Medicine; Washington University School of Medicine; St. Louis, MO USA; Medicine Service; Veterans Affairs Medical Center; St. Louis, MO USA.
George M MunsonDepartment of Microbiology and Immunology; University of Miami; Miller School of Medicine; Miami, FL USA.
David A RaskoDepartment of Microbiology and Immunology; University of Maryland School of Medicine; Baltimore, MD USA; Institute for Genome Sciences; University of Maryland School of Medicine; Baltimore, MD USA.

Funding

Novel Antigen Identification for an Enterotoxigenic E. coli VaccineR01AI089894 · NIAID · WASHINGTON UNIVERSITY · PI Zachary T. Berndsen, James Michael Fleckenstein · 2010 to 2026
$7.4M
Molecular Pathogenesis of Enterotoxigenic Escherichia coli InfectionsI01BX001469 · VA · ST. LOUIS VA MEDICAL CENTER · PI FLECKENSTEIN, JAMES MICHAEL · 2013 to 2017
–
BLRD VA I01 BX001469NIAID NIH HHS R01 AI089894NIAID NIH HHS R01AI89894
6 · The paper itself

Abstract

The enterotoxigenic Escherichia coli are a pervasive cause of serious diarrheal illness in developing countries. Presently, there is no vaccine to prevent these infections, and many features of the basic pathogenesis of these organisms remain poorly understood. Until very recently most pathogenesis studies had focused almost exclusively on a small subset of known "classical" virulence genes, namely fimbrial colonization factors and the heat-labile (LT) and heat stable (ST) enterotoxins. However, recent investigations of pathogen-host interactions reveal a surprisingly complex and intricately orchestrated engagement involving the interplay of classical and "novel" virulence genes, as well as participation of genes highly conserved in the E. coli species. These studies may inform further rational approaches to vaccine development for these important pathogens.

Indexed as

Enterotoxigenic Escherichia coliEpithelial CellsHumansadhesinsbacterialenterotoxigenic Escherichia coliEscherichia coli vaccinesgene expression profilinghost-pathogen interactiontranscriptome

Identifiers

PMID23892244
PMCPMC3839984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.